Abeona Therapeutics
Price & Volume
Stats
See more52W Range | $3.05-$8.45 |
Market Cap | $241.5M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$34.3M |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 15 days ago
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 27 days ago
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
Yahoo Finance • last year
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
Yahoo Finance • last year
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
About
CEO | Dr. Vishwas Seshadri M.B.A., Ph.D. |
Address | 6555 Carnegie Avenue, Cleveland, OH, United States, 44103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
